Safety of Lifitegrast Ophthalmic Solution 5.0% in Patients With Dry Eye Disease: A 1-Year, Multicenter, Randomized, Placebo-Controlled Study

PURPOSE: To evaluate the 1-year safety of lifitegrast ophthalmic solution 5.0% in patients with dry eye disease compared with placebo. METHODS: SONATA (Safety Of a 5.0% coNcentrATion of lifitegrAst ophthalmic solution) was a multicenter, randomized, prospective, double-masked, placebo-controlled pha...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Cornea
Prif Awduron: Donnenfeld, Eric D., Karpecki, Paul M., Majmudar, Parag A., Nichols, Kelly K., Raychaudhuri, Aparna, Roy, Monica, Semba, Charles P.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Cornea 2016
Pynciau:
Clinical Science
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4859202/
https://ncbi.nlm.nih.gov/pubmed/27055211
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/ICO.0000000000000803
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg